The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

INTRODUCTION: This study investigated the diagnostic and disease‐monitoring potential of plasma biomarkers in mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia and cognitively unimpaired (CU) individuals. METHODS: Plasma was analyzed using Simoa assays from 99 CU, 107 MCI, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Simrén, Joel, Leuzy, Antoine, Karikari, Thomas K., Hye, Abdul, Benedet, Andréa Lessa, Lantero‐Rodriguez, Juan, Mattsson‐Carlgren, Niklas, Schöll, Michael, Mecocci, Patrizia, Vellas, Bruno, Tsolaki, Magda, Kloszewska, Iwona, Soininen, Hilkka, Lovestone, Simon, Aarsland, Dag, Hansson, Oskar, Rosa‐Neto, Pedro, Westman, Eric, Blennow, Kaj, Zetterberg, Henrik, Ashton, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359457/
https://www.ncbi.nlm.nih.gov/pubmed/33491853
http://dx.doi.org/10.1002/alz.12283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359457/
https://www.ncbi.nlm.nih.gov/pubmed/33491853
http://dx.doi.org/10.1002/alz.12283

Ejemplares similares